The In Vitro Diagnostics (IVD) Market was valued at $80.9 billion in 2024. This market is expected to reach $123.28 billion by 2032 from an estimated $84.78 billion in 2025, at a CAGR of 5.5% during the forecast period from 2025 to 2032. IVD Market Size & Forecast The ...

The Kenya IVD Market was valued at $53.43 million in 2024. This market is expected to reach $68.66 million by 2032 from an estimated $55.23 million in 2025, at a CAGR of 3.2% during the forecast period of 2025-2032. Kenya IVD Market Size & Forecast The growth ...

The Côte d’Ivoire IVD Market was valued at $21.0 million in 2024. This market is expected to reach $25.8 million by 2032 from an estimated $21.5 million in 2025, at a CAGR of 2.6% during the forecast period of 2025-2032. Côte d’Ivoire IVD Market Size & Forecast The ...

The Europe IVD Market is expected to reach $39.77 billion by 2032 at a CAGR of 3.7% from 2025 to 2032. In vitro diagnostics (IVD) are tests performed on biological samples such as blood, saliva, and other tissues taken from the human body to detect a wide range ...

The South East Asia IVD Market is expected to record a CAGR of 7% from 2025 to 2032, reaching $4.11 billion by 2032. In vitro diagnostics (IVD) are tests performed on biological samples such as blood, saliva, and other tissues taken from the human body to detect ...

The Asia-Pacific IVD Market was valued at $21.09  billion in 2024. This market is expected to reach $36.02  billion by 2032, from an estimated $22.44  billion in 2025, at a CAGR of 7% during the forecast period 2025-2032. In vitro diagnostics (IVD) is focused ...

The Middle East IVD Market was valued at $1.57  billion in 2024. This market is expected to reach $2.15  billion by 2032, from an estimated $1.63  billion in 2025, at a CAGR of 4.1% during the forecast period 2025-2032. Middle East IVD Market Size & Forecast In ...

The Latin American IVD Market is expected to register a CAGR of 5.5% during the forecast period 2023–2030 to reach $6.45 billion by 2030. The burden of communicable and non-communicable diseases, the rise in medical tourism, the shift toward decentralized testing, ...

The Indonesia IVD Market is expected to reach $1.11 billion by 2029, at a CAGR of 10.6% from 2022 to 2029. The growth of this market is driven by the high prevalence of infectious and chronic diseases and the growing awareness regarding the importance of early ...

The Nepal IVD Market is expected to grow at a CAGR of 12.3% from 2022 to 2029 to reach $62.7 million by 2029. The growth of the Nepal in-vitro diagnostics market is mainly attributed to the increasing prevalence of infectious & non-communicable diseases and initiatives ...